Clinical Trials Logo

Clinical Trial Summary

Topical therapy with retinoids is the only proven medical therapy for aged/photoaged human skin. However, topical therapy with retinoids often result in unwanted cutaneous dermatitis, including erythema and scaling. The reseachers intend to investigate the dose, frequency of use, and time dependence of topical retinol-induced dermatitis. The researchers intend to evaluate retinoid-induced dermatitis biochemically, including retinol regulation of retinoid responsive genes that control retinoid metabolism and serve as markers for retinoid bioactivity. The researchers will also investigate the role of EGF receptor pathway in retinoid-induced dermatitis.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT00857610
Study type Observational
Source University of Michigan
Contact
Status Completed
Phase
Start date July 20, 2009
Completion date August 29, 2014

See also
  Status Clinical Trial Phase
Completed NCT00323921 - Determination of Safety and Efficacy of a Laser With Cooling for Treatment of Skin N/A
Completed NCT03629405 - Assessment of the Efficacy and Barrier Protection of Two Cosmetic Products N/A
Completed NCT02403986 - An Efficacy and Safety Study Evaluating Treatment Sessions of Restylane Skinboosters Vital Lidocaine in the Face Phase 4